Dr Reddy's Lab recalls over 4,000 bottles of generic drug in US

Dr Reddy's Lab recalls over 4,000 bottles of generic drug in US

The Hyderabad-based drug major is recalling 4,320 bottles of Tacrolimus Capsules which are used to prevent the body from rejecting a transplanted organ

FPJ Web DeskUpdated: Tuesday, March 07, 2023, 05:16 PM IST
article-image
Dr Reddy's Lab recalls over 4,000 bottles of generic drug in US | Image: Dr. Reddy's (Representative)

Dr Reddy's Laboratories is recalling over 4,000 bottles of a generic drug in the US due to a packaging error.

The Hyderabad-based drug major is recalling 4,320 bottles of Tacrolimus Capsules which are used to prevent the body from rejecting a transplanted organ.

New Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to "Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules," USFDA said in its latest Enforcement Report.

The affected lot was produced at the company's Bachupally-based manufacturing plant and marketed in the US by its American arm.

Dr Reddy's initiated the Class II nationwide recall on February 8 this year.

As per USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

IndianOil Board approves setting up Paradip Petrochemical Complex for Rs 61,077 cr

IndianOil Board approves setting up Paradip Petrochemical Complex for Rs 61,077 cr

Government selling 3.5% stake in HAL to raise Rs 2,867 crore

Government selling 3.5% stake in HAL to raise Rs 2,867 crore

Credit Suisse buyout to take away 12,000 jobs; experts demand rescue package for staffers

Credit Suisse buyout to take away 12,000 jobs; experts demand rescue package for staffers

Bajaj Consumer Care buys back 74,799 shares

Bajaj Consumer Care buys back 74,799 shares

Mukesh Ambani overtakes Gautam Adani as India's richest, despite losing 20% wealth

Mukesh Ambani overtakes Gautam Adani as India's richest, despite losing 20% wealth